Literature DB >> 33172515

COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks.

Ana Alina Haiduc1, Michael Ogunjimi2, Rohma Shammus1, Saira Mahmood1, Ramesh Kutty3, Attilio Lotto3,4,5, Rafael Guerrero3, Amer Harky3,6,4,7, Ram Dhannapuneni3.   

Abstract

OBJECTIVE: We aimed to examine the literature to determine if both paediatric and adult patients diagnosed with congenital heart disease (CHD) are at a higher risk of poor outcomes if they have the coronavirus disease 2019 (COVID-19), compared to those without CHD.
METHODS: A systematic review was executed using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. To identify articles related to COVID-19 and CHD, an extensive literature search was performed on EMBASE, Medline, Scopus, and Global Health databases using keywords and MeSH terms.
RESULTS: A total of 12 articles met the inclusion criteria and were included for analysis in this systematic review. Two themes were identified for data extraction: evidence supporting higher risks in CHD patients and evidence against higher risks in CHD patients. After combining the data, there were 99 patients with CHDs out of which 12 required admissions to ICU.
CONCLUSION: This systematic review suggests that CHD may increase the risk of poor outcomes for those with COVID-19, but also highlights the necessity for more research with larger sample sizes in order to make a more justified conclusion, as the majority of papers that were analysed were case series and case reports. Future research should aim to quantify the risks if possible whilst accounting for various confounding factors such as age and treatment history.

Entities:  

Keywords:  Coronavirus; cardiac surgery; congenital; outcomes; paediatric; risks

Year:  2020        PMID: 33172515     DOI: 10.1017/S1047951120003741

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  7 in total

1.  The spectrum of COVID-19 in complex adult congenital heart disease: A case series.

Authors:  Ioannis Farmakis; Diamantis Kosmidis; Christos Liantzakis; Evangelia Serasli; Haralambos Karvounis; Athanasios Koutsakis; George Giannakoulas
Journal:  Int J Cardiol Congenit Heart Dis       Date:  2021-02-18

2.  Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US.

Authors:  Louis Ehwerhemuepha; Bradley Roth; Anita K Patel; Olivia Heutlinger; Carly Heffernan; Antonio C Arrieta; Terence Sanger; Dan M Cooper; Babak Shahbaba; Anthony C Chang; William Feaster; Sharief Taraman; Hiroki Morizono; Rachel Marano
Journal:  JAMA Netw Open       Date:  2022-05-02

3.  ASE Statement on Adapting Pediatric, Fetal, and Congenital Heart Disease Echocardiographic Services to the Evolving COVID-19 Pandemic.

Authors:  Carolyn A Altman; Mary T Donofrio; Bhawna Arya; Melissa Wasserman; Gregory J Ensing; Meryl S Cohen; Mark B Lewin; Madhav Swaminathan; Piers C A Barker
Journal:  J Am Soc Echocardiogr       Date:  2021-01-28       Impact factor: 5.251

Review 4.  Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement.

Authors:  Marcello Lanari; Elisabetta Venturini; Luca Pierantoni; Giacomo Stera; Guido Castelli Gattinara; Susanna Maria Roberta Esposito; Silvia Favilli; Emilio Franzoni; Eleonora Fusco; Paolo Lionetti; Claudio Maffeis; Gianluigi Marseglia; Laura Massella; Fabio Midulla; Alberto Zanobini; Marco Zecca; Alberto Villani; Annamaria Staiano; Luisa Galli
Journal:  Ital J Pediatr       Date:  2022-01-12       Impact factor: 2.638

Review 5.  COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.

Authors:  Berenice Martínez-Salazar; Melle Holwerda; Chiara Stüdle; Indre Piragyte; Nadia Mercader; Britta Engelhardt; Robert Rieben; Yvonne Döring
Journal:  Front Cell Dev Biol       Date:  2022-02-15

Review 6.  The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System.

Authors:  Mohammed S Alqahtani; Mohamed Abbas; Abdullah Alsabaani; Amjad Alqarni; Hussain M Almohiy; Entisar Alsawqaee; Raghad Alshahrani; Shahd Alshahrani
Journal:  Infect Drug Resist       Date:  2022-03-22       Impact factor: 4.003

7.  Describing characteristics of adults with and without congenital heart defects hospitalized with COVID-19.

Authors:  Perla Diaz; Will Coughlin; Wilson Lam; Peter Ermis; David Aguilar; Cecilia M Ganduglia Cazaban; A J Agopian
Journal:  Birth Defects Res       Date:  2022-06-11       Impact factor: 2.661

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.